Chemotherapy
Research from Institute for Clinical Molecular Biology in chemotherapy provides new insights
Published in Cancer Weekly, May 4th, 2010
"Here, we describe the process of ribosome biogenesis as a target of a large variety of chemotherapeutic drugs. We determined the inhibitory concentration of 36 chemotherapeutic drugs for transcription and processing of ribosomal RNA by in vivo labeling experiments. Inhibitory drug concentrations were correlated to the loss of nucleolar integrity. The synergism of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-05-04)
More Articles from Cancer Weekly
- American Association for Cancer Research
Statins do not protect patients against risk of colorectal adenoma - Georgetown University Medical Center
Breast cancer risk tied to grandmother's diet - Helmholtz Association of German Research Centres
Prostate cancer: Risk increases with the number of affected family members - Imperial College London
You had me at hello: Frisky yeast know who to 'shmoo' after 2 minutes - Journal of the National Cancer Institute
Association of fiber and colorectal cancer risk differs depending on dietary assessment method - Journal of the National Cancer Institute
Magnitude of overdiagnosis in cancer indicates need for strategies to address the problem - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
